-Caveat Lector-
 
Oct. 4, 2004. 07:07 PM
 
Miro Cernetig  
Graham Fraser  
Richard Gwyn  
Stephen Handelman  
Chantal Hebert  
James Travers  
Ian Urquhart  
Thomas Walkom  
Canadian class action suit launched over Vioxx

FROM CANADIAN PRESS

VANCOUVER — Just days after the arthritis drug Vioxx was pulled from store shelves, a class action lawsuit has been launched in B.C. Supreme Court alleging negligence by drug maker Merck and Co. Inc.

Jim Poyner, the lawyer behind the lawsuit, said there was no reason to delay starting a lawsuit.

"There are some (lawsuits) that have all the appearances of being open and shut," he said.

In one of the biggest drug recalls in history, Merck ordered Vioxx from the shelves last week after studies found the drug may increase heart attack and stroke risk.

The statement of claim filed under the Class Proceedings Act alleges negligence on several fronts, including failure to adequately test and follow up on studies of the safety of the drug.

A judge must certify the class action suit before it can proceed.

The lawsuit claims Merck noticed problems with Vioxx as early as 2000, but failed to issue adequate warnings.

The suit also alleges that pharmacists and physicians in Canada weren't given the same warnings about side effects as those in the U.S.

American pamphlets cautioned about potential heart attacks and other serious cardiovascular events for patients taking Vioxx.

Poyner said the warnings were greater and in more detail in the U.S. compared to warnings issued in Canada.

"It seems to me we may have a situation, and we've seen this many times, where Canadians are treated differently than the Americans."

A statement of defence has not yet been filed by the drug company. A company spokesman could not be reached for comment.

The lawsuit names Lyle Richards, a Vancouver construction project manager, as the plaintiff who had been taking Vioxx for two years because of injuries he received from a car accident.

"The plaintiff and other proposed class members have been placed in a position where they have probably sustained or will sustain serious personal injuries," the suit notes.

Poyner says many people have already called his office asking about the lawsuit.

Jay Fiddler, who just refilled a $130 Vioxx prescription before the recall, is considering joining the lawsuit.

She said she'd like to participate to force the company to produce safer drugs.

The 33-year-old PhD student at the University of B.C. has Stills disease, an adult onset of juvenile rheumatoid arthritis, and couldn't get out of bed without Vioxx.

"It was fantastic. . . I took double doses."

Fiddler had been taking Vioxx for four years.

Researchers conducting the study on the drug showed higher risks of cardiovascular problems in those taking the drug for at least 18 months.

Fiddler said she hasn't experienced any signs of cardiovascular problems, but admits she was shocked when the drug was recalled.

"We take a lot of drugs that have all kinds of side effects," Fiddler said "This one seems more severe, a bit more frightening."

Fiddler will soon try another anti-inflammatory drug.

"I'm a lot stiffer in the morning, there's a lot more pain." she said. "I'm using my cane more."

The lawsuit claims since the drugs' introduction into the Canadian market, Vioxx has become the 10th most prescribed drug in the country, with three million prescriptions written in 2002.

Estimated sales of Vioxx in Canada in 2003 were valued at $200 million.

Data released last week showed that people died out of almost 1,300 participants in the three-year Vioxx study.

The same number of people died in the placebo part of the study, however 45 participants on Vioxx had cardiovascular problems as compared to 25 on placebo.

Merck voluntarily pulled the drug from the market.


› Be Thankful! Subscribe now and Save 50%!




Legal Notice: Copyright Toronto Star Newspapers Limited. All rights reserved. Distribution, transmission or republication of any material from www.thestar.com is strictly prohibited without the prior written permission of Toronto Star Newspapers Limited. For information please contact us using our webmaster form. www.thestar.com online since 1996.

www.ctrl.org DECLARATION & DISCLAIMER ========== CTRL is a discussion & informational exchange list. Proselytizing propagandic screeds are unwelcomed. Substance—not soap-boxing—please! These are sordid matters and 'conspiracy theory'—with its many half-truths, mis- directions and outright frauds—is used politically by different groups with major and minor effects spread throughout the spectrum of time and thought. That being said, CTRLgives no endorsement to the validity of posts, and always suggests to readers; be wary of what you read. CTRL gives no credence to Holocaust denial and nazi's need not apply.

Let us please be civil and as always, Caveat Lector. ======================================================================== Archives Available at:

http://www.mail-archive.com/[EMAIL PROTECTED]/ <A HREF="">ctrl</A> ======================================================================== To subscribe to Conspiracy Theory Research List[CTRL] send email: SUBSCRIBE CTRL [to:] [EMAIL PROTECTED]

To UNsubscribe to Conspiracy Theory Research List[CTRL] send email: SIGNOFF CTRL [to:] [EMAIL PROTECTED]

Om

Attachment: site=thestar&page=printer&spacedesc=banner
Description: Binary data

Reply via email to